Re: Molecular testing to deliver personalised chemotherapy recommendations

Peter Gibbs1, Wei Hong2, Jeanne Tie2

  • 1Division of Personalised Oncology, Walter and Eliza Hall Institute, Parkville, Melbourne, Australia. peter.gibbs@mh.org.au.

BMC Medicine
|September 6, 2023
PubMed
Summary

Biomarker validation in cancer medicine is crucial for personalized treatment. Ongoing discussions focus on optimal clinical trial designs to ensure evidence-based biomarker integration for improved patient care.